We just got the first new Alzheimer’s drug in nearly 2 decades

Hello,

Welcome to Insider Healthcare. I’m Lydia Ramsey Pflanzer, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let’s get to it…


AP19295518927022
Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. Biogen’s drug was tested against carriers of the APOE gene, which is linked to Alzheimer’s, and non-carriers. Matt York/Associated Press

The FDA just approved the first new Alzheimer’s drug in 18 years

Here’s what you need to know>>


A patient consulting with a medical professional at an Iora Health clinic.
A patient consulting with a medical professional at an Iora Health clinic. Courtesy Iora Health

One Medical is making a $2.1 billion bet on a rival that upended medical care for seniors

Get the full story>>


Alzheimer's brain scan
Maree Valenta, who has Alzheimer’s disease, undergoes a scan to detect early Alzheimer’s in 2004. Photo by Fairfax Media via Getty Images/Fairfax Media via Getty Images via Getty Images

An old Medicare policy could stand in the way of millions of Alzheimer’s patients looking to get the first approved treatment in nearly 2 decades

Find out more>>


More stories we’re reading:


– Lydia